A systematic review and meta-analysis of the effects of probiotics on bone outcomes in rodent models

J Bone Miner Res. 2024 Dec 31;40(1):100-113. doi: 10.1093/jbmr/zjae187.

Abstract

Emerging evidence demonstrates an opportunity for using probiotics to support bone health, but findings in humans are limited. This systematic review investigated if probiotic supplementation improves bone mineral density (BMD) and bone structure in rodent models compared to no supplementation. Studies (n = 71) examining the effect of oral consumption of any probiotic strain on BMD or bone structure in rodents were included. Meta-analyses were conducted separately by study model (intact, ovariectomized) and bone site (femur, tibia, spine) to determine the probiotic effect (standardized mean difference, SMD) on volumetric BMD (vBMD), bone volume fraction (BV/TV), and cortical thickness (Ct.Th). Reasons for heterogeneity were explored (probiotic genus, sex, type of rodent). In intact rodents, probiotics resulted in greater vBMD (SMD = 0.43, 95% CI [0.13, 0.74], I2 = 3%, p < 0.05) and higher BV/TV (SMD = 0.63, 95% CI [0.25, 1.02], I2 = 57%, p < 0.05) at the femur without changes in cortical bone structure. In ovariectomized models, probiotic supplementation resulted in greater vBMD (femur: SMD = 1.28, 95% CI [1.01, 1.55], I2 = 3%, p < 0.05; tibia: SMD = 1.29, 95% CI [0.52, 2.05], I2 = 67%, p < 0.05; and spine: SMD = 1.47, 95% CI [0.97, 1.97], I2 = 26%, p < 0.05) as well as higher BV/TV (femur: SMD = 1.16, 95% CI [0.80, 1.52], I2 = 56%, p < 0.05; tibia: SMD = 2.13, 95% CI [1.09, 3.17], I2 = 79%, p < 0.05; spine: SMD = 2.04, 95% CI [1.17, 2.90], I2 = 76%, p < 0.05) and Ct.Th at the tibia (SMD = 2.35; 95% CI [0.72, 3.97], I2 = 82%, p < .0.05) but not at the femur versus control. The syntheses support probiotics as a strategy to improve bone outcomes in rodent models.

Keywords: BMD; DXA; bone QCT/μCT; preclinical studies; probiotics; rodents.

Plain language summary

Probiotics are beneficial bacteria that can colonize the gut and produce a health benefit to the host. This includes supporting a healthy skeleton. However, the effects of probiotics in human bone remain uncertain due to the limited number of studies. Rodent models are helpful to explore potential probiotic effects in the context of different life stages and health conditions to inform the design of future clinical trials. This review and meta-analysis investigated if probiotic supplementation improves bone mineral density and bone structure in rodent models compared to no supplementation. Overall, the results demonstrated promising evidence for using probiotics as a strategy to support bone health in rodents, particularly for attenuating bone loss associated with estrogen deficiency in rats and mice.

Publication types

  • Systematic Review
  • Meta-Analysis

MeSH terms

  • Animals
  • Bone Density* / drug effects
  • Bone and Bones / drug effects
  • Female
  • Humans
  • Probiotics* / pharmacology
  • Rodentia